EMEA-000380-PIP05-18

Key facts

Invented name
Cosentyx
Active substance
Secukinumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0144/2019
PIP number
EMEA-000380-PIP05-18
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of hidradenitis suppurativa
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Novartis Europharm Limited

E-mail: paediatric.enquiries@novartis.com
Tel. +41 613246715

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Related content

How useful was this page?

Add your rating